Refine
Year of publication
Language
- English (83)
Is part of the Bibliography
- yes (83)
Keywords
- gamma rays: general (24)
- radiation mechanisms: non-thermal (20)
- ISM: supernova remnants (14)
- gamma rays: galaxies (13)
- galaxies: active (12)
- cosmic rays (11)
- acceleration of particles (8)
- ISM: clouds (6)
- astroparticle physics (6)
- gamma rays: ISM (6)
Landslide hazard motivates the need for a deeper understanding of the events that occur before, during, and after catastrophic slope failures. Due to the destructive nature of such events, in situ observation is often difficult or impossible. Here, we use data from a network of 58 seismic stations to characterise a large landslide at the Askja caldera, Iceland, on 21 July 2014. High data quality and extensive network coverage allow us to analyse both long- and short-period signals associated with the landslide, and thereby obtain information about its triggering, initiation, timing, and propagation. At long periods, a landslide force history inversion shows that the Askja landslide was a single, large event starting at the SE corner of the caldera lake at 23:24:05 UTC and propagating to the NW in the following 2 min The bulk sliding mass was 7-16 x 10(10) kg, equivalent to a collapsed volume of 35-80 x 10(6) m(3). The sliding mass was displaced downslope by 1260 +/- 250 m. At short periods, a seismic tremor was observed for 30 min before the landslide. The tremor is approximately harmonic with a fundamental frequency of 2.3 Hz and shows time-dependent changes of its frequency content. We attribute the seismic tremor to stick-slip motion along the landslide failure plane. Accelerating motion leading up to the catastrophic slope failure culminated in an aseismic quiescent period for 2 min before the landslide. We propose that precursory seismic signals may be useful in landslide early-warning systems. The 8 h after the main landslide failure are characterised by smaller slope failures originating from the destabilised caldera wall decaying in frequency and magnitude. We introduce the term "afterslides" for this subsequent, declining slope activity after a large landslide.
Rapid decline of glomerular filtration rate estimated from creatinine (eGFRcrea) is associated with severe clinical endpoints. In contrast to cross-sectionally assessed eGFRcrea, the genetic basis for rapid eGFRcrea decline is largely unknown. To help define this, we meta-analyzed 42 genome-wide association studies from the Chronic Kidney Diseases Genetics Consortium and United Kingdom Biobank to identify genetic loci for rapid eGFRcrea decline. Two definitions of eGFRcrea decline were used: 3 mL/min/1.73m(2)/year or more ("Rapid3"; encompassing 34,874 cases, 107,090 controls) and eGFRcrea decline 25% or more and eGFRcrea under 60 mL/min/1.73m(2) at follow-up among those with eGFRcrea 60 mL/min/1.73m(2) or more at baseline ("CKDi25"; encompassing 19,901 cases, 175,244 controls). Seven independent variants were identified across six loci for Rapid3 and/or CKDi25: consisting of five variants at four loci with genome-wide significance (near UMOD-PDILT (2), PRKAG2, WDR72, OR2S2) and two variants among 265 known eGFRcrea variants (near GATM, LARP4B). All these loci were novel for Rapid3 and/or CKDi25 and our bioinformatic follow-up prioritized variants and genes underneath these loci. The OR2S2 locus is novel for any eGFRcrea trait including interesting candidates. For the five genome-wide significant lead variants, we found supporting effects for annual change in blood urea nitrogen or cystatin-based eGFR, but not for GATM or (LARP4B). Individuals at high compared to those at low genetic risk (8-14 vs. 0-5 adverse alleles) had a 1.20-fold increased risk of acute kidney injury (95% confidence interval 1.08-1.33). Thus, our identified loci for rapid kidney function decline may help prioritize therapeutic targets and identify mechanisms and individuals at risk for sustained deterioration of kidney function.
Rapid decline of glomerular filtration rate estimated from creatinine (eGFRcrea) is associated with severe clinical endpoints. In contrast to cross-sectionally assessed eGFRcrea, the genetic basis for rapid eGFRcrea decline is largely unknown. To help define this, we meta-analyzed 42 genome-wide association studies from the Chronic Kidney Diseases Genetics Consortium and United Kingdom Biobank to identify genetic loci for rapid eGFRcrea decline. Two definitions of eGFRcrea decline were used: 3 mL/min/1.73m(2)/year or more ("Rapid3"; encompassing 34,874 cases, 107,090 controls) and eGFRcrea decline 25% or more and eGFRcrea under 60 mL/min/1.73m(2) at follow-up among those with eGFRcrea 60 mL/min/1.73m(2) or more at baseline ("CKDi25"; encompassing 19,901 cases, 175,244 controls). Seven independent variants were identified across six loci for Rapid3 and/or CKDi25: consisting of five variants at four loci with genome-wide significance (near UMOD-PDILT (2), PRKAG2, WDR72, OR2S2) and two variants among 265 known eGFRcrea variants (near GATM, LARP4B). All these loci were novel for Rapid3 and/or CKDi25 and our bioinformatic follow-up prioritized variants and genes underneath these loci. The OR2S2 locus is novel for any eGFRcrea trait including interesting candidates. For the five genome-wide significant lead variants, we found supporting effects for annual change in blood urea nitrogen or cystatin-based eGFR, but not for GATM or (LARP4B). Individuals at high compared to those at low genetic risk (8-14 vs. 0-5 adverse alleles) had a 1.20-fold increased risk of acute kidney injury (95% confidence interval 1.08-1.33). Thus, our identified loci for rapid kidney function decline may help prioritize therapeutic targets and identify mechanisms and individuals at risk for sustained deterioration of kidney function.